As a pharmaceutical/healthcare professional, you know how valuable Key Opinion Leaders (KOLs) are to your organisation and how they contribute to the success of your clinical research. In today's competitive and challenging market, it is vital that relationship between the pharmaceutical/healthcare industry and KOLs are not only built but nurtured and maintained.Identifying and engaging KOLs for your organisation is crucial to the success of your product. Entering European markets is a challenge faced by the pharmaceutical industry with ever-changing pricing structures and regulations. Working closely and adopting a culture of transparent collaboration and engagement with KOLs helps overcome some of these challenges.SMi is proud to present KOL Management focused to keep our audience up-to-date with developments in the ever-changing KOL sphere. Reasons why you should attend:Hear directly from Key Opinion Leaders Find out about all the latest regulatory guidance in the European marketsIdentify and engage with KOL through effective social media and traditional channelsGain an insight into current transparent and flexible relationshipsImprove your relationship with key leadersOvercoming cultural barriers and dealing with change managementEstablishing the return on investment for your KOL and MSL managementDevelop a successful KOL management programKeynote Speakers include:Audrey Craven, President, European Federation of Neurological Associations (EFNA)Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)Mario Ottiglio, Associate Director, Public Affairs & Global Health Policy, IFPMAMichal Konstacky, Medical Affairs Director, TakedaKeith Allan, Head of Global Advocacy, Novartis Sanjita Panchal, Medical Scientific Liaison, Merck Neil Ranasinghe, Medical Sciences Manager, Oncology, Immunology & Neuroscience, Bristol-Myers Squibb **Book by 31st May 2012 and Save £300** Alternatively contact Shilan Chandi on tel: +44 (0) 20 7827 6738